Molecular docking studies indicated that Compound 1 has a strong binding affinity to the mTOR protein, with a binding energy of −10.391 kcal/mol, suggesting it may effectively inhibit mTOR, a key player in cancer cell growth and proliferation [221]. This evidence concerns the gene MTOR and cancer.